Business Context and Reporting Period
Company: IDEAYA Biosciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 12, 2019
Reporting Period: Second quarter ended June 30, 2019
Business Context: The Company is an emerging growth company incorporated in Delaware, trading on The Nasdaq Global Select Market under the symbol IDYA. This filing announces financial results for the second quarter of 2019 and the release of a new corporate presentation.
Key Financial Metrics
The provided text serves as a cover document referencing a press release (Exhibit 99.1) for detailed financial data. Consequently, specific numerical values for the following metrics are not present in the filing text:
- Revenue: Not provided in text.
- Profit/Loss: Not provided in text.
- Cash Flow: Not provided in text.
- Margins: Not provided in text.
- Debt and Liquidity: Not provided in text.
Material Changes
The filing text does not contain specific comparative data or descriptions of material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for quarter-over-quarter analysis.
Guidance, Outlook, and Management Commentary
Management Commentary: The Company announced its financial results for the second quarter ended June 30, 2019, via a press release furnished as Exhibit 99.1.
Outlook and Guidance: No specific forward-looking guidance or outlook figures are included in the text of this 8-K.
Regulation FD Disclosure: On August 12, 2019, the Company began utilizing a new corporate presentation (Exhibit 99.2).
Risks and Contingencies: The filing includes standard disclaimers stating that the information furnished in Items 2.02 and 7.01 is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Verify the specific revenue, net loss, and cash position figures in the attached Press Release (Exhibit 99.1), as they are not listed in the 8-K text.
- Review the new Corporate Presentation (Exhibit 99.2) for updated strategic direction or pipeline milestones.
- Confirm the Company's status as an "Emerging Growth Company" and its election regarding extended transition periods for accounting standards.
- Note that the financial information in this filing is furnished, not filed, limiting its incorporation by reference in future securities offerings.